IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank50
3Y CAGR+0.2%
5Y CAGR-1.1%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+0.2%/yr
Annual compound
5Y CAGR
-1.1%/yr
Consistent
Percentile
P50
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 13.60 | -95.3% |
| 2024 | 290.56 | +259.1% |
| 2023 | 80.92 | +499.1% |
| 2022 | 13.51 | -49.4% |
| 2021 | 26.72 | +85.9% |
| 2020 | 14.37 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |